Screener
LeMaitre Vascular LMAT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Net income | $17,050 | $13,779 | $32,729 | $24,790 |
| Earnings per share of common stock: | ||||
| Basic | $0.75 | $0.61 | $1.43 | $1.10 |
| Diluted | $0.74 | $0.60 | $1.42 | $1.08 |
| Weighted-average shares outstanding: | ||||
| Basic | 22,858 | 22,614 | 22,830 | 22,592 |
| Diluted | 24,531 | 22,892 | 24,505 | 22,896 |
| Cash dividends declared per common share | $0.25 | $0.20 | $0.50 | $0.40 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's EPS (diluted)?
- LeMaitre Vascular (LMAT) reported EPS (diluted) of $0.74 in Q2 2026.
- How has LeMaitre Vascular's EPS (diluted) changed year-over-year?
- LeMaitre Vascular's EPS (diluted) increased by 23.3% year-over-year, from $0.60 to $0.74.
- What is the long-term trend for LeMaitre Vascular's EPS (diluted)?
- Over 4 years (2021 to 2025), LeMaitre Vascular's EPS (diluted) has grown at a 18.8% compound annual growth rate (CAGR), from $1.26 to $2.51.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about LeMaitre Vascular's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude